Announcements Trials

Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 4 Depression 4 Head and Neck Neoplasms 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Fatigue 2 Anxiety Disorders 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Sleep Wake Disorders 1 Recurrence 1 Radiation Fibrosis Syndrome 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Acceptance of Health Care 1 Pain 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Calculi 1 Inflammatory Breast Neoplasms 1 Immune Checkpoint Inhibitor-Induced Dermatitis 1 Health Education 1 Constriction, Pathologic 1

Interventions

rozanolixizumab 5 ravulizumab 5 zilucoplan 4 fludarabine 3 Cyclophosphamide 3 telitacicept 2 inebilizumab 2 talquetamab 1 remibrutinib 1 iptacopan 1 efgartigimod alfa 1 Therapeutics 1 Prednisone 1 Prednisolone 1 Plasma Exchange 1 Immunoglobulins, Intravenous 1 HBM9161 1 Cladribine 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Therapeutics × 90 days × Clear all

NCT07570589 2026-05-11

REAL MG PRO

Centre Hospitalier Universitaire de Nice

Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡